126 related articles for article (PubMed ID: 37200057)
1. CD8+ T-cell clones in immune thrombocytopenia.
Blood; 2023 May; 141(20):2543. PubMed ID: 37200057
[No Abstract] [Full Text] [Related]
2. TEMRA: the CD8 subset in chronic ITP?
Lazarus AH; Semple JW
Blood; 2023 May; 141(20):2409-2410. PubMed ID: 37200060
[No Abstract] [Full Text] [Related]
3. The role of CD8+ T-cell clones in immune thrombocytopenia.
Malik A; Sayed AA; Han P; Tan MMH; Watt E; Constantinescu-Bercu A; Cocker ATH; Khoder A; Saputil RC; Thorley E; Teklemichael A; Ding Y; Hart ACJ; Zhang H; Mitchell WA; Imami N; Crawley JTB; Salles-Crawley II; Bussel JB; Zehnder JL; Adams S; Zhang BM; Cooper N
Blood; 2023 May; 141(20):2417-2429. PubMed ID: 36749920
[TBL] [Abstract][Full Text] [Related]
4. T-cell large granular lymphocytic (LGL) leukemia consists of CD4
Kuwahara N; Kodaka T; Zushi Y; Sasaki M; Goka T; Maruoka H; Aoyama Y; Tsunemine H; Yamane T; Kobayashi J; Kawakami T; Ishida F; Itoh T; Takahashi T
J Clin Exp Hematop; 2019; 59(4):202-206. PubMed ID: 31866622
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune thrombocytopenia with clonal expansion of CD8-positive T cells after autologous peripheral blood stem cell transplantation for diffuse large B-cell lymphoma.
Isobe T; Tanimoto TE; Nakaji G; Miyamoto T; Yamasaki S; Takase K; Numata A; Fukuda T; Nagafuji K; Inaba S; Harada M
Bone Marrow Transplant; 2005 Feb; 35(3):315-6. PubMed ID: 15568035
[No Abstract] [Full Text] [Related]
6. Increased cytotoxic potential of CD8
Vrbensky JR; Arnold DM; Kelton JG; Smith JW; Jaffer AM; Larché M; Clare R; Ivetic N; Nazy I
Br J Haematol; 2020 Mar; 188(5):e72-e76. PubMed ID: 31850531
[No Abstract] [Full Text] [Related]
7. CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia.
Ma L; Simpson E; Li J; Xuan M; Xu M; Baker L; Shi Y; Yougbaré I; Wang X; Zhu G; Chen P; Prud'homme GJ; Lazarus AH; Freedman J; Ni H
Blood; 2015 Jul; 126(2):247-56. PubMed ID: 26036802
[TBL] [Abstract][Full Text] [Related]
8. Study of CD4
El-Rashedi FH; El-Hawy MA; Helwa MA; Abd-Allah SS
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):8-14. PubMed ID: 28183683
[TBL] [Abstract][Full Text] [Related]
9. Abnormal lipid rafts related ganglioside expression and signaling in T lymphocytes in immune thrombocytopenia patients.
Zhang X; Zhang D; Liu W; Li H; Fu R; Liu X; Xue F; Yang R
Autoimmunity; 2016; 49(1):58-68. PubMed ID: 26287565
[TBL] [Abstract][Full Text] [Related]
10. Contributions of T lymphocyte abnormalities to therapeutic outcomes in newly diagnosed patients with immune thrombocytopenia.
Zhao Z; Yang L; Yang G; Zhuang Y; Qian X; Zhou X; Xiao D; Shen Y
PLoS One; 2015; 10(5):e0126601. PubMed ID: 25978334
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21-5p Regulates CD3+T Lymphocytes Through VCL and LTF in Patients with Immune Thrombocytopenia.
He X; Wang T; Ran N; Liu C; Xing L; Shao Z
Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975534
[TBL] [Abstract][Full Text] [Related]
12. T cell receptor V gene usage by CD4+ and CD8+ peripheral blood T lymphocytes in immune thrombocytopenic purpura.
Hedlund-Treutiger I; Elinder G; Wigzell H; Grunewald J; Wahlström J
Acta Paediatr; 2004 May; 93(5):633-7. PubMed ID: 15174786
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Peripheral Blood Lymphocytes for Primary Immune Thrombocytopenia.
Lu J; Sun L; Wu X; Li T; Men L
Contrast Media Mol Imaging; 2022; 2022():9833941. PubMed ID: 36072617
[TBL] [Abstract][Full Text] [Related]
14. Immune Status and Chemokine C Receptor 7 Expression in Primary in Patients with Immune Thrombocytopenia.
Zhang L; Zhou GZ; Feng WY; Li D
Turk J Haematol; 2022 Feb; 39(1):29-37. PubMed ID: 34445858
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte subpopulations: a potential predictor of a response in patients with immune thrombocytopenia.
Žibřidová K; Souček O; Krčmová LK; Jankovičová K; Gančarčíková M; Pejková MA; Drugda J; Nováková D; Košťál M
Hematology; 2024 Dec; 29(1):2304486. PubMed ID: 38251842
[TBL] [Abstract][Full Text] [Related]
16. T cell-mediated autoimmunity in immune thrombocytopenia.
Vrbensky JR; Nazy I; Clare R; Larché M; Arnold DM
Eur J Haematol; 2022 Jan; 108(1):18-27. PubMed ID: 34487584
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte subsets in primary immune thrombocytopenia.
Rong W; Yan-xiang Z; Shan-shan X; Ju-mei S
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):816-9. PubMed ID: 24911458
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of chronic immune thrombocytopenic purpura.
Cines DB; McMillan R
Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CD4/CD8 ratio in children with immune thrombocytopenic purpura (ITP) after treatment with intravenous immunoglobulin (IVIG).
Zhang W; Qian X; Chen W
Cell Mol Biol (Noisy-le-grand); 2022 May; 68(5):186-191. PubMed ID: 36029490
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD154 (CD40L) on stimulated T lymphocytes in patients with idopathic thrombocytopenic purpura.
Song I; Kim J; Kwon K; Koo S; Jo D
Hematology; 2016 Apr; 21(3):187-92. PubMed ID: 26183367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
